Neuropathic Pain Symptom Inventory (NPSI)

Bouhassira D

Distributed by Mapi Research Trust


Distributed by Mapi Research Trust

Basic description

  • Published in 2004.

WEBINAR:  An Author Webinar on the Neuropathic Pain Symptom Inventory - Recorded session available here!


Bouhassira D

NPSI © 2004. Bouhassira D. et al. All rights reserved
To evaluate the different symptoms of neuropathic pain
Therapeutic area
  • Nervous System Diseases
  • Pathological Conditions, Signs and Symptoms
Therapeutic indication


Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • French for France
Bibliographic reference(s) of the original questionnaire

Bouhassira D, Attal N, Fermanian J, Alchaar H, Gautron M, Masquelier E, Rostaing S, Lanteri-Minet M, Collin E, Grisart J, Boureau F. Development and validation of the Neuropathic Pain Symptom Inventory. Pain. 2004 Apr;108(3):248-57 (full text article)

Attal N, Fermanian C, Fermanian J, Lanteri-Minet M, Alchaar H, Bouhassira D. Neuropathic pain: are there distinct subtypes depending on the aetiology or anatomical lesion? Pain. 2008 Aug 31;138(2):343-53  

Access this questionnaire

Please proceed below

Login SIGN up free

Contact and conditions of use


Bouhassira D

« Pathophysiology and Clinical Pharmacology of Pain »
Centre d’Evaluation et de Traitement de la Douleur
Hôpital Ambroise Paré
9, Avenue Charles de Gaulle
92100 Boulogne-Billancourt
Tel : +33 1 49 09 45 56
Fax : +33 1 49 09 44 35
E-mail: didier.bouhassira@inserm.fr

Didier Bouhassira's publications (PubMed)

Contact information

Mapi Research Trust
27 rue de la Villette
69003 Lyon
Phone: +33 (0)4 72 13 66 66

Conditions of use

Students, physicians, clinical practice, academic users

You may access the questionnaire and/or its available translations directly (see tutorial). Should you not see the Download button, please contact us.

Healthcare organizations, commercial users & IT companies

Fees may apply to your project. Submit your request (see tutorial). Our PROVIDE team will get back to you with the needed information and license agreement in a timely manner.

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.


Original language(s)

  • French for France


The list of available translations is subject to constant changes and may not be exhaustive. It is provided for information only. Some recently produced translations may not be included in the list below yet. Please do check the status of available translations with Mapi Research Trust / the developers / copyright holders / distributors.

Also, the listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study.


Afrikaans for South Africa
Armenian for Armenia
Bengali for India*
Bulgarian for Bulgaria*
Chinese for Hong Kong
Chinese for Malaysia
Chinese for Taiwan
Croatian for Croatia*
Czech for Czech Republic
Danish for Denmark*
Dutch for Belgium (Flemish)*
Dutch for the Netherlands*
English for Australia*
English for Canada
English for India*
English for South Africa
English for the UK*
English for the USA
Finnish for Finland*
French for Belgium*
French for Canada
French for Switzerland
Georgian for Georgia
German for Austria*
German for Germany*
German for Switzerland
Greek for Greece
Hindi for India
Hungarian for Hungary*
Indonesian for Indonesia
Italian for Italy
Italian for Switzerland*
Japanese for Japan*
Kannada for India
Korean for South Korea
Latvian for Latvia
Lithuanian for Lithuania
Malay for Malaysia
Malay for Singapore
Malayalam for India
Mandarin for China*
Mandarin for Singapore
Mandarin for Taiwan
Marathi for India
Norwegian for Norway*
Polish for Poland*
Portuguese for Brazil
Portuguese for Portugal
Punjabi for India
Romanian for Romania*
Russian for Latvia
Russian for Russia
Russian for Ukraine
Serbian for Serbia*
Slovak for Slovakia*
Slovenian for Slovenia*
Spanish for Argentina
Spanish for Chile*
Spanish for Colombia
Spanish for Costa Rica
Spanish for Mexico*
Spanish for Panama
Spanish for Peru*
Spanish for Spain*
Spanish for Venezuela
Spanish for the USA*
Swedish for Finland*
Swedish for Sweden*
Tagalog for the Philippines
Tamil for India
Telugu for India
Thai for Thailand
Turkish for Turkey
Ukrainian for Ukraine
Urdu for India
Urdu for Pakistan
* Performed by Mapi

BiblioPRO: you can find information about the Spanish version here - puede encontrar información sobre la versión española aqui

The author has selected Mapi/ICON Language Services as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.

For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).

Conditions to translate

Academic Translation

If you wish to translate the questionnaire:

  1. Log in or Register for free
  2. Submit your request for translation online (Tutorials are available on our FAQs)
  3. Our PROVIDE team will send you a translation agreement along with Linguistic Validation Guidelines.

Commercial Users

Exclusive vendor for translation work for commercial users: Mapi/ICON Language Services

More information on translations

Bibliographic references of the translations:

Lu LC, Chang SY, Liu CY, Tsay SL. Reliability and validity of the Chinese version neuropathic pain symptom inventory in patients with colorectal cancer. J Formos Med Assoc. 2018 Nov;117(11):1019-1026 (Full text article)

Bouhassira D, Attal N, Fermanian J, Alchaar H, Gautron M, Masquelier E, Rostaing S, Lanteri-Minet M, Collin E, Grisart J, Boureau F. Development and validation of the Neuropathic Pain Symptom Inventory. Pain. 2004 Apr;108(3):248-57 (full text article)

Sommer C, Richter H, Rogausch JP, Frettlöh J, Lungenhausen M, Maier C. A modified score to identify and discriminate neuropathic pain: a study on the German version of the Neuropathic Pain Symptom Inventory (NPSI). BMC Neurol. 2011 Aug 23;11:104 (Full text article)

Padua L, Briani C, Jann S, Nobile-Orazio E, Pazzaglia C, Morini A, Mondelli M, Ciaramitaro P, Cavaletti G, Cocito D, Fazio R, Santoro L, Galeotti F, Carpo M, Plasmati R, Benedetti L, Schenone A, Marchettini P, Cruccu G. Validation of the Italian version of the Neuropathic Pain Symptom Inventory in peripheral nervous system diseases. Neurol Sci. 2009 Apr;30(2):99-106 (PubMed abstract)

Matsubayashi Y, Takeshita K, Sumitani M, Oshima Y, Tonosu J, Kato S, Ohya J, Oichi T, Okamoto N, Tanaka S. Psychometric Validation of the Japanese Version of the Neuropathic Pain Symptom Inventory. PLoS One. 2015 Nov 24;10(11):e0143350 (Full text article)

Villoria J, Rodríguez M, Berro MJ, Stern A, Sánchez-Magro I. Psychometric validation of the neuropathic pain symptom inventory for its use in Spanish. J Pain Symptom Manage. 2011 Jul;42(1):134-46 (PubMed abstract)

Euasobhon P, Soonthornkes N, Rushatamukayanunt P, Wangnamthip S, Jirachaipitak S, Maneekut N, Laurujisawat J, Srirojanakul W. Psychometric Validity and Reliability of the Thai Version of the Neuropathic Pain Symptom Inventory. J Med Assoc Thai. 2016 May;99(5):557-64 (PubMed abstract)

Focus groups in six countries (U.S. [English], Brazil [Portuguese], Japan [Japanese], China [Mandarin], Finland [Finnish], Spain [Spanish]):
Crawford B, Bouhassira D, Wong A, Dukes E. Conceptual adequacy of the neuropathic pain symptom inventory in six countries. Health Qual Life Outcomes. 2008 Aug 18;6:62 (Full text article)



Implemented electronically on TrialMax Slate® site-based devices



Implemented electronically on TrialMax Touch® home-based devices

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us